Cortactin's Role in Breast Tumor Development in Mice
Author Information
Author(s): Agnes G. van Rossum, Maaike P. van Bragt, Ellen Schuuring-Scholtes, Jan C. M. van der Ploeg, Johan H. J. M. van Krieken, Philip M. Kluin, Ed Schuuring
Primary Institution: Leiden University Medical Center
Hypothesis
Does overexpression of human cortactin in mammary glands affect tumor development in mice?
Conclusion
The study concludes that overexpression of human cortactin does not increase the development of breast tumors in mice.
Supporting Evidence
- Cortactin overexpression did not lead to an increased incidence of breast tumors in transgenic mice.
- The incidence of tumors in MMTV-cortactin mice was lower than in wild-type controls.
- Histological analysis showed no significant differences in tumor types between transgenic and wild-type mice.
Takeaway
The researchers wanted to see if a protein called cortactin could help mice develop breast tumors, but it turns out it didn't help at all.
Methodology
Transgenic mice were created and analyzed for tumor development through various breeding and histological examinations.
Potential Biases
Potential bias due to the specific inbred mouse strain used, which may not represent broader populations.
Limitations
The study's findings may be influenced by the genetic background of the mice and the long latency period for tumor development.
Participant Demographics
Female mice from the FVB/N inbred strain were used in the study.
Statistical Information
P-Value
0.034
Statistical Significance
p=0.034
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website